Literature DB >> 2527856

Lumbar facet joint syndrome. A randomised clinical trial.

G Lilius1, E M Laasonen, P Myllynen, A Harilainen, G Grönlund.   

Abstract

A group of 109 patients with unilateral low back pain for over three months were randomised to receive one of three types of injection treatment: cortisone and local anaesthetic injected into two facet joints (28), the same mixture around two facet joints (39), or physiological saline into two facet joints (42). The effect of the treatment was evaluated in relation to work attendance, pain, disability and movements of the lumbar spine. Patients were examined one hour and two and six weeks after treatment and also completed a questionnaire after three months. A significant improvement was observed in work attendance, pain and disability scores, but this was independent of the treatment given and movements of the lumbar spine were not improved. Of the 70 patients with initial pain relief after injection, 36% reported persisting benefit at the three month follow-up, independent of the mode of treatment given. We conclude that facet joint injection is a non-specific method of treatment and the good results depend on a tendency to spontaneous regression and to the psychosocial aspects of back pain.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2527856

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  27 in total

1.  The lumbar multifidus muscles are affected by medial branch interventions for facet joint syndrome: potential problems and proposal of a pericapsular infiltration technique.

Authors:  J Gossner
Journal:  AJNR Am J Neuroradiol       Date:  2011-11-03       Impact factor: 3.825

Review 2.  The lumbar facet joint: a review of current knowledge: Part II: diagnosis and management.

Authors:  Gerard P Varlotta; Todd R Lefkowitz; Mark Schweitzer; Thomas J Errico; Jeffrey Spivak; John A Bendo; Leon Rybak
Journal:  Skeletal Radiol       Date:  2010-06-26       Impact factor: 2.199

3.  MR-guided facet joint injection therapy using an open 1.0-T MRI system: an outcome study.

Authors:  Patrick Freyhardt; Tony Hartwig; Maximilian De Bucourt; Martin Maurer; Diane Renz; Bernhard Gebauer; Bernd Hamm; Ulf K M Teichgräber; Florian Streitparth
Journal:  Eur Radiol       Date:  2013-06-28       Impact factor: 5.315

Review 4.  Intra-articular facet joint injections for low back pain: a systematic review.

Authors:  Rajni Vekaria; Ree'thee Bhatt; David R Ellard; Nicholas Henschke; Martin Underwood; Harbinder Sandhu
Journal:  Eur Spine J       Date:  2016-02-23       Impact factor: 3.134

5.  Facet Joint Pain and the Role of Neural Blockade in Its Management.

Authors: 
Journal:  Curr Rev Pain       Date:  1999

Review 6.  Steroids Spinal Injections.

Authors:  Stefano Marcia; Chiara Zini; Joshua A Hirsch; Ronil V Chandra; Matteo Bellini
Journal:  Semin Intervent Radiol       Date:  2018-11-05       Impact factor: 1.513

Review 7.  Role of facet joints in spine pain and image-guided treatment: a review.

Authors:  J L Bykowski; W H W Wong
Journal:  AJNR Am J Neuroradiol       Date:  2011-09-22       Impact factor: 3.825

8.  Consensus practice guidelines on interventions for lumbar facet joint pain from a multispecialty, international working group.

Authors:  Steven P Cohen; Arun Bhaskar; Anuj Bhatia; Asokumar Buvanendran; Tim Deer; Shuchita Garg; W Michael Hooten; Robert W Hurley; David J Kennedy; Brian C McLean; Jee Youn Moon; Samer Narouze; Sanjog Pangarkar; David Anthony Provenzano; Richard Rauck; B Todd Sitzman; Matthew Smuck; Jan van Zundert; Kevin Vorenkamp; Mark S Wallace; Zirong Zhao
Journal:  Reg Anesth Pain Med       Date:  2020-04-03       Impact factor: 6.288

9.  Lumbar zygapophysial joint radiofrequency denervation: a long-term clinical outcome study.

Authors:  Elizabeth Marie Manejias; Jason Hu; Yusuf Tatli; Gregory E Lutz
Journal:  HSS J       Date:  2008-07-15

Review 10.  [Diagnostics and minimally invasive therapy for chronic low back pain].

Authors:  M A Rauschmann; J Warzecha; M Arabmotlagh; A Mayer; D V Stechow
Journal:  Schmerz       Date:  2004-12       Impact factor: 1.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.